Definium Therapeutics, Inc. Operating Expenses
Definium Therapeutics, Inc. (DFTX) reported Operating Expenses of $75.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- Definium Therapeutics, Inc. operating expenses for the quarter ending 2026-06-30 was $75.08M, a 83.55% increase year-over-year.
- Definium Therapeutics, Inc. operating expenses for the quarter ending 2026-03-31 was $59.22M, a 84.15% increase year-over-year.
- Definium Therapeutics, Inc. operating expenses for the quarter ending 2025-12-31 was $47.58M, a 46.57% increase year-over-year.
- Definium Therapeutics, Inc. operating expenses for the quarter ending 2025-09-30 was $45.67M, a 84.21% increase year-over-year.
- Definium Therapeutics, Inc. operating expenses for fiscal 2025 was $166.31M, a 60.04% increase from fiscal 2024.
- Definium Therapeutics, Inc. operating expenses for fiscal 2024 was $103.92M, a 10.71% increase from fiscal 2023.
- Definium Therapeutics, Inc. operating expenses for fiscal 2023 was $93.87M, a 41.51% increase from fiscal 2022.
- Definium Therapeutics, Inc. operating expenses for fiscal 2022 was $66.33M, a 29.33% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 7 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $75.08M 10-Q · filed 2026-08-06 | $134.30M 10-Q · filed 2026-08-06 | $181.88M derived: sum of 3 quarters · filed 2026-08-06 | $227.54M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $59.22M 10-Q · filed 2026-05-07 | $106.80M derived: sum of 2 quarters · filed 2026-05-07 | $152.47M derived: sum of 3 quarters · filed 2026-05-07 | $193.37M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $47.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $93.25M derived: sum of 2 quarters · filed 2026-02-26 | $134.15M derived: sum of 3 quarters · filed 2026-08-06 | $166.31M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $45.67M 10-Q · filed 2025-11-06 | $86.57M derived: sum of 2 quarters · filed 2026-08-06 | $118.73M 10-Q · filed 2025-11-06 | $151.19M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $40.90M 10-Q · filed 2026-08-06 | $73.06M 10-Q · filed 2026-08-06 | $105.52M derived: sum of 3 quarters · filed 2026-08-06 | $130.32M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $32.16M 10-Q · filed 2026-05-07 | $64.62M derived: sum of 2 quarters · filed 2026-05-07 | $89.41M derived: sum of 3 quarters · filed 2026-05-07 | $113.87M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $32.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $57.25M derived: sum of 2 quarters · filed 2026-02-26 | $81.71M derived: sum of 3 quarters · filed 2026-02-26 | $103.92M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $24.79M 10-Q · filed 2025-11-06 | $49.25M derived: sum of 2 quarters · filed 2025-11-06 | $71.45M 10-Q · filed 2025-11-06 | $93.66M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $24.46M 10-Q · filed 2025-07-31 | $46.66M 10-Q · filed 2025-07-31 | $68.87M derived: sum of 3 quarters · filed 2025-07-31 | $90.48M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | $22.20M 10-Q · filed 2025-05-08 | $44.41M derived: sum of 2 quarters · filed 2025-05-08 | $66.03M derived: sum of 3 quarters · filed 2025-05-08 | $95.21M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $22.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $43.82M derived: sum of 2 quarters · filed 2025-03-06 | $73.00M derived: sum of 3 quarters · filed 2025-03-06 | $93.87M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $21.62M 10-Q · filed 2024-11-07 | $50.80M derived: sum of 2 quarters · filed 2024-11-07 | $71.66M 10-Q · filed 2024-11-07 | $85.56M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $29.18M 10-Q · filed 2024-08-13 | $50.05M 10-Q · filed 2024-08-13 | $63.95M derived: sum of 3 quarters · filed 2024-08-13 | $80.93M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $20.86M 10-Q · filed 2024-05-08 | $34.76M derived: sum of 2 quarters · filed 2024-05-08 | $51.74M derived: sum of 3 quarters · filed 2024-05-08 | $68.69M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $13.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $30.88M derived: sum of 2 quarters · filed 2024-02-28 | $47.83M derived: sum of 3 quarters · filed 2024-02-28 | $66.33M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $16.98M 10-Q · filed 2023-11-02 | $33.93M derived: sum of 2 quarters · filed 2023-11-02 | $52.43M 10-Q · filed 2023-11-02 | $69.99M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | $16.94M 10-Q · filed 2023-08-03 | $35.45M 10-Q · filed 2023-08-03 | $53.01M derived: sum of 3 quarters · filed 2023-08-03 | $70.23M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $18.50M 10-Q · filed 2023-05-04 | $36.06M derived: sum of 2 quarters · filed 2023-05-04 | $53.29M derived: sum of 3 quarters · filed 2023-05-04 | $98.51M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $17.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $34.78M derived: sum of 2 quarters · filed 2023-03-09 | $80.00M derived: sum of 3 quarters · filed 2023-03-09 | $93.85M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $17.23M 10-Q · filed 2022-11-10 | $62.45M derived: sum of 2 quarters · filed 2022-11-10 | $76.30M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $45.22M 10-Q · filed 2022-08-11 | $59.07M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $13.85M 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | $33.03M 10-K · filed 2022-03-28 | ||||
| 2019-12-31 | $10.73M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |